Navigation Links
Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
Date:11/15/2007

establishes non-inferiority. Under this analysis, the study met the radiographic success rate endpoint in the mITT population. Since p>0.05, there is not a statistically significant difference between cethromycin and Biaxin, which supports non-inferiority.

  • Bacteriological cure rate- cethromycin 95.9% (70 subjects/73 subjects) compared to Biaxin 97.1% (67 subjects/69 subjects). The bacteriologically evaluable population for each arm of the trial was not powered to demonstrate statistical non-inferiority at a 95% confidence interval.

  • Percent of bacteriologically evaluable patients- approximately 33% of subjects in the per protocol population were bacteriologically evaluable. The Company believes that this percentage of bacteriologically evaluable patients is consistent with rates observed in precedent successful antibiotic drug approvals and that it will add to its existing bacteriologically evaluable patient database for cethromycin.

  • Discontinuation rate- from the modified intent-to-treat population, discontinuation rate due to adverse events was 4.2% for cethromycin and 2.8% for Biaxin.

Cethromycin demonstrated a favorable safety profile in Trial CL-05. The incidence of adverse events was not statistically different between cethromycin and Biaxin. The most common adverse events reported in patients receiving cethromycin were mild-to-moderate diarrhea (cethromycin 4.5%, Biaxin 4.1%), headache (cethromycin 2.4%, Biaxin 3.1%), nausea (cethromycin 4.5%, Biaxin 1.4%), vomiting (cethromycin 1.4%, Biaxin 1.0%), abdominal pain (cethromycin 1.4%, Biaxin 1.4%) and taste disturbance (cethromycin 7.6%, Biaxin 2.1%). No drug-related serious adverse events were observed in any study subject. Liver function tests and electrocardiogram monitoring in Trial CL-05 demonstrated no significant differences between subjects receiving cethromycin and subjects receiving Biaxin.

This is consiste
'/>"/>

Contact: Melanie Nimrodi
mnimrodi@mww.com
312-546-3508
MWW Group
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
2. Kaiser Permanente Achieves Climate Action Leader Status
3. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
4. LMS integrated obstetrics solution achieves general availability
5. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
6. Pharsight Achieves $7.3 Million in Quarterly Revenue
7. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
8. Burgeoning Population of Hepatitis C Virus Patients in Need of Second- and Third-Line Treatment Options
9. Medical Services International Maintains Pace in Second Quarter
10. CEOs Need an Advertising Check Up or Second Opinion
11. Trojan(R) Ranks U.S. Colleges and Universities in Second Annual Sexual Health Report Card
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2014)... (PRWEB) July 26, 2014 According to ... Vkool.com, this is a comprehensive bodybuilding program that helps ... using anabolic steroids . The program also instructs ... without cardio. , Vkool reveals in its review ... workouts that can help men get ripped and jacked ...
(Date:7/26/2014)... The birth control safety center at ... of new legal information on the site. A federal ... of lawsuits pending for July alleging side effects from ... those using popular prescription drugs and medical devices. By ... legal news all in one place, they can see ...
(Date:7/25/2014)... Dallas, TX (PRWEB) July 26, 2014 ... China Laser Scanning Confocal Microscope Industry” is ... China Laser Scanning Confocal Microscope market. The ... information, including Laser Scanning Confocal Microscope definition, ... as industry overview. This research covers international market ...
(Date:7/25/2014)... New York, New York (PRWEB) July 25, 2014 ... for dismissal and summary judgment in two DePuy Pinnacle ... cases, paving the way for the claims to go ... LLP reports. In an opinion rendered on July 18th, ... of Texas, ruled that the two Plaintiffs’ claims may ...
(Date:7/25/2014)... July 25, 2014 Consuming too much ... to know? , Read the labels! , Learn to ... how it relates to health during a "Healthy Eating ... 1 at Humility House, 755 Ohltown Road, Austintown. , ... an informational discussion and answer questions. , The ...
Breaking Medicine News(10 mins):Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 2Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 3Health News:DrugNews Adds Latest Court Updates on Mirena IUD Lawsuits 2Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 2Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 3Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 4Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 2Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 4Health News:Learn to Decipher Food Labels at Humility House 2
... , Achievements in Research, Education and Advocacy Cause for Celebration ... 2009 will be remembered as a year of many firsts for ... potential new treatment for lupus, the launch of the first-ever Ad ... on the barriers to lupus drug development. And it appears ...
... Washington, D.C. -- A new study in the journal ... drug-resistant strains of Acinetobacter, a dangerous type of bacteria ... study is being posted online today and will appear ... patients in hospital intensive care units (ICUs) and others ...
... on hundreds of other genes that help disease spread ... in concert seem to spur the deadliest form of brain ... life last August. , Scientists reporting in the Dec. 23 ... duo of genes are turned on in about 60 percent ...
... available in German . , Many brain training ... products even claim that brain training can prevent dementia in old ... brain exercises can have this effect. That is what the German ... in information published on informedhealthonline.org today. ...
... , WATERTOWN, Mass., Dec. 23 To strengthen ... season, Exergen® Corporation has introduced sponsorship of "game-time temperature" ... upcoming College Bowl football games. , The "Exergen Game-Time ... the thermometry industry and is currently running on Sunday ...
... Visiting Physicians Association, which is based in Farmington ... state of Michigan $9.5 million to settle allegations that ... false claims to Medicare, TRICARE and the Michigan Medicaid ... Association is a Michigan professional corporation which has provided ...
Cached Medicine News:Health News:2009: A Year of Many Firsts in Efforts to Overcome Lupus 2Health News:2009: A Year of Many Firsts in Efforts to Overcome Lupus 3Health News:2009: A Year of Many Firsts in Efforts to Overcome Lupus 4Health News:2009: A Year of Many Firsts in Efforts to Overcome Lupus 5Health News:2009: A Year of Many Firsts in Efforts to Overcome Lupus 6Health News:New study shows rise in drug resistance of dangerous infection in US hospitals 2Health News:Two Genes Work in Tandem to Spur Deadliest Brain Cancer 2Health News:Brain training can help improve specific abilities in older people 2Health News:Exergen TemporalScanner Sponsors 'Game Time Temperature' for NFL and College Bowl Games 2Health News:Visiting Physicians Association to Pay $9.5 Million to Resolve False Claims Act Allegations 2
(Date:7/24/2014)... , Germany , and ... , Exclusive global license from ... SF3B1 mutations, including next-generation sequencing (NGS) gene panels, for ... be targeted by new test, indicate favorable prognosis for ... QIAGEN sees potential for developing companion diagnostics ...
(Date:7/24/2014)...  IRIDEX Corporation (NASDAQ: IRIX ) today ... financial results after the market closes on Thursday, ... the Company will host a conference call with the ... Thursday, July 31, 2014 to discuss ... Interested parties may access the live conference ...
(Date:7/24/2014)...  IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey ... financial results for the second quarter ended June 30, 2014. ... revenues of $6.5 million in the second quarter of 2014, ... , Total revenues of $13.3 million for the six ... the same period in 2013 , Total revenues generated ...
Breaking Medicine Technology:QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7
... the art software package designed to assist in ... by a lens manufacturer with years of experience ... is designed to help you run your lab ... the software dictates., ,Designed specifically for integrated retail ...
... The table-mounted knee retractor ... for total knee arthroplasty ... open-frame design allows for ... knee during the procedure. ...
... for every general surgery need. No matter ... the GO550/GO500 Omni-Flex General Retractor Systems give ... simplest way possible., ,With large and small ... arm, the GO550 provides comprehensive flexibility and ...
... sounds you need to hear! ... body sounds while reducing distracting ... Model 3000., ,With Ambient Noise ... 18 times amplification, and a ...
Medicine Products: